CN1168503C - Veterinarian virus kind biological product heat resisting freeze drying protective agent and its preparation technique - Google Patents
Veterinarian virus kind biological product heat resisting freeze drying protective agent and its preparation technique Download PDFInfo
- Publication number
- CN1168503C CN1168503C CNB011388714A CN01138871A CN1168503C CN 1168503 C CN1168503 C CN 1168503C CN B011388714 A CNB011388714 A CN B011388714A CN 01138871 A CN01138871 A CN 01138871A CN 1168503 C CN1168503 C CN 1168503C
- Authority
- CN
- China
- Prior art keywords
- protecting agent
- freeze
- heat
- distilled water
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
The present invention relates to a heat-resistance freeze-drying protecting agent for veterinarian virus biological products, and a preparation process thereof. Various kinds of protecting agents are respectively mixed with each other according to ingredients and proportions. The present invention is characterized in that effective ingredients of each protecting agent are respectively sterilized, the effective ingredients which can be sterilized at high pressure are dissolved in distilled water in a preparation proportion and are sterilized at 116 DEG C for 30 to 40 minutes, and ingredients which can not resist high temperature are also dissolved in distilled water in a preparation proportion and are filtered by a filter film with a hole diameter of 0.22 mum for sterilization; then, the two kinds of ingredients are mixed with each other so as to obtain the freeze-drying heat-resistance protecting agent; when used, the freeze-drying heat-resistance protecting agent is added to virus antigen liquid in a proportion of 1:1; then, a mixed solution of the protecting agent and the virus antigen liquid is packaged and freeze-dried. Freeze-dried shapes of products of the present invention can still be maintained after the products are preserved for 24 months at 2 to 8 DEG C, and the virus content is lower than standard content specified for veterinarian biological products in China. The present invention relates to a product with the advantages of low cost and long effect, and a preparation method thereof, and the present invention solves the long existing problem of high cost for transporting and preserving veterinarian biological products.
Description
Technical field
The present invention relates to the Freeze Drying Technique of biological product, preservation adjuvant and manufacture method thereof.
Background technology
China's veterinary biological product protective agent commonly used at present is mainly 5% sucrose skim milk and 5-10% sucrose, the 1.5-3% gelatin, and goods require cryopreservation (below 15 ℃), and the storage life of 2-8 ℃ of condition only 3-9 month must use up at normal temperatures as early as possible.This is just for the preservation of veterinary biological product, transportation, use etc. bring many difficulties and inconvenience, simultaneously owing to must cryopreservation causing energy resource consumption and storage cost big.
At present, the flourishing in the world biological freeze-dried products of national veterinary almost all is that 2-8 ℃ of preservation is more than 24 months.But the not play-by-play of square method.Chinese patent CN1176827A " a kind of manufacture method of freeze-dried live vaccine for animal use " proposes to adopt with polyvinylpyrrolidone, sodium carboxymethyl cellulose; tamarind gum; sodium glutamate; trehaloses etc. are the freeze drying protectant that the formulated of main matrix freeze drying protectant becomes; the method that freeze-drying curve that employing adapts with it and newcastle disease vaccine virus antigen are made the newcastle disease freeze-dried live vaccine, but this Seedling long preservation under 2-8 ℃ of condition.
Summary of the invention
The purpose of this invention is to provide weak malicious freeze dried vaccine heat-resisting lyophilized protecting agent of a kind of newcastle disease and preparation technology, reduce protective condition, extend using period and reduce use cost.
The preparation technology of the weak malicious freeze dried vaccine heat-resisting lyophilized protecting agent of newcastle disease, press component, mixed, it is characterized in that protectant active substance is handled degerming respectively: sterilized 30-40 minute for 116 ℃ to being dissolved in the distilled water in the preparation ratio by autoclaved material (1); (2) material with non-refractory also is dissolved in the distilled water in the preparation ratio, with aperture 0.22 μ m membrane filtration degerming; After finishing degerming respectively (1), (2) two kinds of compositions are mixed, be the lyophilizing heat resisting protective, add in the virus antigen liquid in 1: 1 ratio during use, carry out lyophilization after the packing.
The preparation of preparation technology's preparation of the present invention can be preserved more than 24 months under 2-8 ℃ of condition, can reach every index of regulation in " People's Republic of China's veterinary biological product quality standard ".
The specific embodiment
The weak malicious freeze dried vaccine heat-resisting lyophilized protecting agent of newcastle disease, comprise gelatin commonly used, sucrose, dextrin, it is characterized in that the material component proportioning of heat-resisting lyophilized protecting agent is: gelatin 1.5-2%, sucrose 5-6%, dextrin 5-10%, PVP (K90) 2-5%, sorbitol 2%, sodium glutamate 1-2%; Be the dry component in the preparation, percentage ratio residue part is distilled water.
The preparation technology of the weak malicious freeze dried vaccine heat-resisting lyophilized protecting agent of newcastle disease, comprise that the dry component with above-mentioned heat-resisting lyophilized protecting agent is mixed in proportion, it is characterized in that protectant active substance component is carried out degerming to be handled: (1) is to can autoclaved material: gelatin, sucrose, dextrin, PVP (90), be dissolved in the distilled water 116 ℃ of sterilizations 30-40 minute in ratio separately; (2) with the material of non-refractory: sorbitol, sodium glutamate also are dissolved in the distilled water, in proportion with the membrane filtration degerming of aperture 0.22 μ m; After finishing degerming respectively (1), (2) two kinds of compositions are mixed, be the lyophilizing heat resisting protective, add in the virus antigen liquid in 1: 1 ratio during use, carry out lyophilization after the packing.
Technical parameter and detection method
1. the physical behavior of product, steriling test, mycoplasma check, exogenous virus check, specificity check, safety verification, residual moisture mensuration and vacuum are measured by the method and the standard of " People's Republic of China's veterinary biological product rules " and are undertaken.
2. lyophilization cycle is no more than 48h.
3. protectant toxicity test
Bird vaccine carries out each 20 of collunarium, eye dripping, drinking-water and subcutaneous injections by containing 10 times of amounts protecting dosage in the middle of the product respectively to 7 age in days healthy chicks, observes 20d, and chickling is all strong to live; There is not any untoward reaction.
4. viral level is measured and standard
(1) assay method:
A. make 10 times of serial dilutions by the real tissue mass that contains with sterile saline, get 3 suitable dilution factors, inoculate 5 of 10 age in days SPF Embryo Gallus domesticus in the allantoic cavity respectively, every embryo 0.1mL puts 37 ℃ and continues to hatch, the dead in the past Embryo Gallus domesticus of 48h discards to be disregarded, at the Embryo Gallus domesticus of 48-120h death, take out results Embryo Gallus domesticus liquid at any time, with same dilution Embryo Gallus domesticus liquid mixed in equal amounts, measure the red cell agglutination valency respectively.To 120h, get all embryos of living, gather in the crops Embryo Gallus domesticus liquid one by one, measure the red cell agglutination valency respectively, agglutination titer 〉=160 are judged to infection, calculate EID
50
B. press label and indicate plumage part, vaccine is diluted to 1 plumage part/0.1mL with sterile saline, remake 10 times of serial dilutions, other method is the same, calculates every plumage part EID at last
50Content.
(2) reach standard
Viral loss rate is less than 0.4 titre after A, the lyophilizing.
B. every plumage part viral level 〉=10 after the lyophilizing
6.7EID
50
C. the product after the lyophilizing is put 37 ℃ and is preserved 10d and 30d and carry out viral level and measure, the viral level rate of descent the former within 1 titre, the latter is within 2 titres.
D. product is put 25 ℃ of preservation 30d after the lyophilizing, and the viral level rate of descent is within 0.6 titre.
E. product is put 2-8 ℃ of preservation 24 months, every plumage part viral level 〉=10
6.17EID
50
Claims (2)
1, the weak malicious freeze dried vaccine heat-resisting lyophilized protecting agent of a kind of newcastle disease, comprise gelatin commonly used, sucrose, dextrin, it is characterized in that the material component proportioning of heat-resisting lyophilized protecting agent is: gelatin 1.5-2%, sucrose 5-6%, dextrin 5-10%, PVP (K90) 2-5%, sorbitol 2%, sodium glutamate 1-2%; Be the dry component in the preparation, percentage ratio residue part is distilled water.
2 one kinds of technologies that prepare the weak malicious freeze dried vaccine heat-resisting lyophilized protecting agent of the described newcastle disease of claim 1, comprise that the dry component with above-mentioned heat-resisting lyophilized protecting agent is mixed in proportion, it is characterized in that protectant active substance is carried out degerming to be handled: (1) is to can autoclaved material: gelatin, sucrose, dextrin, PVP (90), be dissolved in the distilled water 116 ℃ of sterilizations 30-40 minute in ratio separately; (2) with the material of non-refractory: sorbitol, sodium glutamate; All be dissolved in the distilled water, with the membrane filtration degerming of aperture 0.22 μ m in ratio separately; After finishing degerming respectively (1), (2) two kinds of compositions are mixed, be the lyophilizing heat resisting protective, add in the virus antigen liquid in 1: 1 ratio during use, carry out lyophilization after the packing.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011388714A CN1168503C (en) | 2001-12-21 | 2001-12-21 | Veterinarian virus kind biological product heat resisting freeze drying protective agent and its preparation technique |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011388714A CN1168503C (en) | 2001-12-21 | 2001-12-21 | Veterinarian virus kind biological product heat resisting freeze drying protective agent and its preparation technique |
Related Child Applications (7)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100295860A Division CN1253209C (en) | 2001-12-21 | 2001-12-21 | Heat-resistant lyophilized protectant of lyophilized vaccine for henpox and preparing process thereof |
CNB2004100295837A Division CN1223375C (en) | 2001-12-21 | 2001-12-21 | Heat resisting lyophilized protectant for chicken infectious bronchitis (H120, H52, Kidney infectious bronchitis W93) lyophilized vaccine and preparing process thereof |
CN 200410029585 Division CN1211122C (en) | 2001-12-21 | 2001-12-21 | Heat-resisting lyophilized protectant for swine fever lapinized hyoptoxicity calf testicular cell vaccine and preparing process |
CNB2004100295822A Division CN1233418C (en) | 2001-12-21 | 2001-12-21 | Heat-resisting lyophilized protectant for chicken newcastle disease, chicken infectious bronchitis (H120, H52) dual lyophilized vaccine and preparing process thereof |
CNB2004100295841A Division CN1222320C (en) | 2001-12-21 | 2001-12-21 | Heat-resistant lyophilized protectant of lyophilized vaccine for chicken infectious laryngotracheitis and preparing process thereof |
CN 200410029587 Division CN1222314C (en) | 2001-12-21 | 2001-12-21 | Heat resisting lyophilized protectant for chicken Marek's disense turkey herpes virus lyophilized vaccine and preparing process thereof |
CN 200410029581 Division CN1251762C (en) | 2001-12-21 | 2001-12-21 | Heat resisting lyophilized protectant for chicken infections Fabianite bursa hypotpxicity (B87) lyophilized vaccine and preparing process thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1426816A CN1426816A (en) | 2003-07-02 |
CN1168503C true CN1168503C (en) | 2004-09-29 |
Family
ID=4674823
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB011388714A Expired - Fee Related CN1168503C (en) | 2001-12-21 | 2001-12-21 | Veterinarian virus kind biological product heat resisting freeze drying protective agent and its preparation technique |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1168503C (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100384993C (en) * | 2005-11-02 | 2008-04-30 | 浙江大学 | Process for increasing stability of elastase of lichen spore bacillus ZJUEL31410 |
CN100418580C (en) * | 2005-11-14 | 2008-09-17 | 中国农业科学院哈尔滨兽医研究所 | Heat resistant freeze drying protectant for chicken Newcastle disease live vaccine and its prepn and application |
CN102397556A (en) * | 2011-05-23 | 2012-04-04 | 上海创宏生物科技有限公司 | Heatproof protection agent for live vaccine of duck viral hepatitis (DVH), preparation method thereof and application thereof |
CN102294028A (en) * | 2011-05-24 | 2011-12-28 | 南京创启生物科技有限公司 | Chicken newcastle disease missing-resistant heat-resistant drinking water-immunization tablet and preparation method thereof |
CN102430126B (en) * | 2011-12-31 | 2013-04-17 | 山东滨州博莱威生物技术有限公司 | Heat-resistant stabilizer for tissue fluid lyophilization, as well as preparation method and application thereof |
CN102641504B (en) * | 2012-04-14 | 2013-06-05 | 青岛农业大学 | Heat-resistant freeze-drying protecting agent for vaccine and preparing method |
CN102626520B (en) * | 2012-04-23 | 2013-07-03 | 青岛农业大学 | Application of heat-resisting cryoprotectant of mink canine distemper live vaccine |
CN102671209B (en) * | 2012-05-30 | 2013-06-05 | 青岛农业大学 | Heat-resistant freeze-drying protective agent for newcastle disease live vaccines and preparation method |
CN102671208B (en) * | 2012-05-30 | 2013-07-03 | 青岛农业大学 | Heat-resisting freeze-dried protective agent for live vaccine for chicken infectious bursal diseases and preparation method for heat-resisting freeze-dried protective agent |
CN102671207B (en) * | 2012-05-30 | 2013-06-05 | 青岛农业大学 | Newcastle disease and avian infectious bronchitis bigeminal live vaccine heat-resisting freeze-drying protective agent and preparation method |
CN102727904B (en) * | 2012-07-04 | 2013-08-28 | 广东大华农动物保健品股份有限公司 | Heat resisting protective agent of bivalent live vaccine against highly pathogenic porcine reproductive and respiratory syndrome-pseudorabies and preparation method thereof |
US9314519B2 (en) * | 2012-08-21 | 2016-04-19 | Intervet Inc. | Liquid stable virus vaccines |
CN103007289B (en) * | 2012-11-09 | 2014-04-23 | 上海创宏生物科技有限公司 | Heat-resisting protective agent for duck virus hepatitis live vaccines and preparation method and application of protective agent |
CN103285399B (en) * | 2013-06-04 | 2015-01-28 | 中国食品药品检定研究院 | Freezing and drying protecting agent for amyxis brucella live vaccine |
CN103341162A (en) * | 2013-07-03 | 2013-10-09 | 青岛易邦生物工程有限公司 | Freeze-dried vaccine of porcine transmissible gastroenteritis |
CN103341176B (en) * | 2013-07-03 | 2015-06-10 | 青岛易邦生物工程有限公司 | Freeze-drying protective agent for vaccines |
CN103893776B (en) * | 2014-03-18 | 2016-04-06 | 中国农业科学院兰州兽医研究所 | Sheep infective pustule virus cell weak-toxic vaccine heat-resisting lyophilized protecting agent and its preparation method and application |
CN105497904B (en) * | 2015-12-22 | 2018-06-26 | 肇庆大华农生物药品有限公司 | A kind of pseudorabies virus vaccine heat-resisting lyophilized protecting agent and preparation method thereof |
CN105497888B (en) * | 2015-12-29 | 2018-07-27 | 瑞普(保定)生物药业有限公司 | A kind of chicken Marek's disease heat resisting protective live vaccine and preparation method thereof |
CN108815517B (en) * | 2018-07-13 | 2021-09-14 | 广东永顺生物制药股份有限公司 | Duck plague live vaccine and preparation method thereof |
-
2001
- 2001-12-21 CN CNB011388714A patent/CN1168503C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1426816A (en) | 2003-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1168503C (en) | Veterinarian virus kind biological product heat resisting freeze drying protective agent and its preparation technique | |
CN102166362B (en) | Porcine reproductive and respiratory syndrome live vaccine heat-resistant freeze-drying protective agent and preparation method thereof | |
DE60035497T2 (en) | PROCEDURE FOR PRESERVING VIRUSES AND MYCOPLASMA | |
CN107281481A (en) | A kind of pseudo- mad dog heat-resisting lyophilized protecting agent of live vaccine, preparation method and freeze dried vaccine and preparation method | |
CN101612396B (en) | Canine distemper live vaccine and preparation method thereof | |
CN1233418C (en) | Heat-resisting lyophilized protectant for chicken newcastle disease, chicken infectious bronchitis (H120, H52) dual lyophilized vaccine and preparing process thereof | |
CN101947321B (en) | Heat-resisting and freeze-drying protector for live vaccine and preparation method thereof as well as live newcastle disease vaccine | |
CN103656661B (en) | Pig japanese b encephalitis heat-resisting lyophilized protecting agent of live vaccine, its preparation method and application | |
CN103336116A (en) | Method for detecting efficacy of classical swine fever live vaccines | |
SU1237081A3 (en) | Method of manufacturing liofilized vaccine against duck hepatitis | |
CN101474410A (en) | Heat-resisting lyophilized protecting agent of live vaccine for animal and preparation method thereof | |
CN1251762C (en) | Heat resisting lyophilized protectant for chicken infections Fabianite bursa hypotpxicity (B87) lyophilized vaccine and preparing process thereof | |
CN1223375C (en) | Heat resisting lyophilized protectant for chicken infectious bronchitis (H120, H52, Kidney infectious bronchitis W93) lyophilized vaccine and preparing process thereof | |
CN1222314C (en) | Heat resisting lyophilized protectant for chicken Marek's disense turkey herpes virus lyophilized vaccine and preparing process thereof | |
CN100418580C (en) | Heat resistant freeze drying protectant for chicken Newcastle disease live vaccine and its prepn and application | |
CN1253209C (en) | Heat-resistant lyophilized protectant of lyophilized vaccine for henpox and preparing process thereof | |
CN1222320C (en) | Heat-resistant lyophilized protectant of lyophilized vaccine for chicken infectious laryngotracheitis and preparing process thereof | |
CN1063971C (en) | Method for preparing freeze-dried live vaccine for animal use | |
CN110404063A (en) | Using the non-method exempted from egg and prepare avian infectious bronchitis virus antigen | |
CN1211122C (en) | Heat-resisting lyophilized protectant for swine fever lapinized hyoptoxicity calf testicular cell vaccine and preparing process | |
CN114042167A (en) | Newcastle disease and infectious bronchitis bivalent live vaccine heat-resistant protective agent and preparation method and application thereof | |
CN102309759B (en) | Poultry freeze-drying live vaccine heat-resisting protective agent and preparation method thereof | |
CN108938574A (en) | Heat resisting protective, preparation method and the usage is lyophilized in pseudorabies disease live-vaccine | |
CN116440282B (en) | Freeze-drying protective agent for live vaccine of infectious bronchitis and preparation method thereof | |
CN103463640A (en) | Canine distemper virus live vaccine heat-resisting cryoprotectant and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |